Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Shares Outstanding (Weighted Average): 2015-2020

Historic Shares Outstanding (Weighted Average) for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2020 value amounting to $6.4 million.

  • Outlook Therapeutics' Shares Outstanding (Weighted Average) rose 350.47% to $6.4 million in Q3 2020 from the same period last year, while for Jun 2020 it was $4.6 million, marking a year-over-year increase of 313.48%. This contributed to the annual value of $23.7 million for FY2024, which is 81.80% up from last year.
  • As of Q3 2020, Outlook Therapeutics' Shares Outstanding (Weighted Average) stood at $6.4 million, which was up 39.18% from $4.6 million recorded in Q2 2020.
  • Over the past 5 years, Outlook Therapeutics' Shares Outstanding (Weighted Average) peaked at $6.4 million during Q3 2020, and registered a low of $142,517 during Q1 2016.
  • In the last 3 years, Outlook Therapeutics' Shares Outstanding (Weighted Average) had a median value of $1.1 million in 2019 and averaged $1.8 million.
  • Data for Outlook Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 350.47% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Shares Outstanding (Weighted Average) stood at $147,368 in 2016, then climbed by 9.17% to $160,878 in 2017, then soared by 230.57% to $531,819 in 2018, then spiked by 183.02% to $1.5 million in 2019, then skyrocketed by 350.47% to $6.4 million in 2020.
  • Its Shares Outstanding (Weighted Average) was $6.4 million in Q3 2020, compared to $4.6 million in Q2 2020 and $2.2 million in Q1 2020.